IGF2 and ovarian carcinoma: IGF‐II, wild‐type (wt) and mutated IGFBP‐6 were shown to determine alteration in the migration of ovarian cancer cells.71 IGFBP‐6 increased migration of SKOV3 ovarian cancer cells (transitional phenotype) in an IGF‐independent manner.